Yu Katayose

3.9k total citations
148 papers, 2.9k citations indexed

About

Yu Katayose is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Katayose has authored 148 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 76 papers in Surgery and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Katayose's work include Pancreatic and Hepatic Oncology Research (40 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers) and Pancreatitis Pathology and Treatment (18 papers). Yu Katayose is often cited by papers focused on Pancreatic and Hepatic Oncology Research (40 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers) and Pancreatitis Pathology and Treatment (18 papers). Yu Katayose collaborates with scholars based in Japan, United States and Canada. Yu Katayose's co-authors include Michiaki Unno, Shinichi Egawa, Fuyuhiko Motoi, Toshiki Rikiyama, Takeshi Naitoh, Hiroki Hayashi, Seiki Matsuno, Tatsuo Hata, Toshio Kudo and Naoaki Sakata and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yu Katayose

139 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Katayose Japan 30 1.4k 1.3k 810 743 401 148 2.9k
Yutaka Yonemura Japan 34 1.1k 0.8× 2.0k 1.5× 1.0k 1.2× 1.5k 2.0× 267 0.7× 107 4.0k
Koji Okabayashi Japan 31 1.2k 0.9× 1.2k 0.9× 760 0.9× 532 0.7× 118 0.3× 177 3.0k
Meier Hsu United States 31 1.3k 0.9× 749 0.6× 871 1.1× 1.4k 1.9× 306 0.8× 131 3.5k
Ryo Hosotani Japan 30 2.1k 1.5× 982 0.7× 1.4k 1.7× 700 0.9× 331 0.8× 127 3.9k
Gakuji Ohshio Japan 28 1.3k 0.9× 995 0.8× 873 1.1× 491 0.7× 312 0.8× 121 2.8k
Uwe A. Wittel Germany 29 1.4k 1.0× 924 0.7× 649 0.8× 644 0.9× 314 0.8× 100 2.4k
Hironori Yamaguchi Japan 35 1.3k 0.9× 1.6k 1.2× 1.2k 1.5× 1.3k 1.7× 93 0.2× 214 4.1k
Kenichi Harada Japan 24 664 0.5× 714 0.5× 1.4k 1.8× 927 1.2× 197 0.5× 170 2.9k
Tamas A. Gonda United States 25 1.5k 1.1× 1.1k 0.8× 771 1.0× 602 0.8× 96 0.2× 108 2.7k
Klaus Kaserer Austria 40 1.3k 0.9× 1.3k 1.0× 722 0.9× 313 0.4× 450 1.1× 108 4.4k

Countries citing papers authored by Yu Katayose

Since Specialization
Citations

This map shows the geographic impact of Yu Katayose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Katayose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Katayose more than expected).

Fields of papers citing papers by Yu Katayose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Katayose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Katayose. The network helps show where Yu Katayose may publish in the future.

Co-authorship network of co-authors of Yu Katayose

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Katayose. A scholar is included among the top collaborators of Yu Katayose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Katayose. Yu Katayose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakagawa, Kei, Shingo Tsujinaka, Yu Katayose, et al.. (2025). Current insights and future perspectives of treatment strategies for biliary tract cancer. World Journal of Gastrointestinal Oncology. 17(10). 110415–110415.
2.
Takahashi, Takao, Kazuyuki Ishida, Yasunori Emi, et al.. (2022). Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial. Cancers. 14(18). 4392–4392. 2 indexed citations
3.
Takami, Kazuhiro, et al.. (2021). Biliary Schwannoma That Required Differentiation from Bile Duct Cancer. SHILAP Revista de lepidopterología. 15(2). 578–586. 3 indexed citations
4.
Shibata, Chikashi, Hitoshi Ogawa, Toru Nakano, et al.. (2019). Influence of age on postoperative complications especially pneumonia after gastrectomy for gastric cancer. BMC Surgery. 19(1). 106–106. 22 indexed citations
5.
Katayose, Yu, Kuniharu Yamamoto, Ryuji Nakamura, et al.. (2015). Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001).. PubMed. 62(138). 303–8. 2 indexed citations
6.
Yoshimatsu, Gumpei, Naoaki Sakata, Haruyuki Tsuchiya, et al.. (2015). The Co-Transplantation of Bone Marrow Derived Mesenchymal Stem Cells Reduced Inflammation in Intramuscular Islet Transplantation. PLoS ONE. 10(2). e0117561–e0117561. 39 indexed citations
7.
Motoi, Fuyuhiko, Yu Katayose, Shinichi Egawa, & Michiaki Unno. (2013). The evaluation of neoadjuvant strategy for pancreatic cancer planned resection. Suizo. 28(1). 25–33. 4 indexed citations
8.
Katayose, Yu, Hideo Ohtsuka, Kunihiro Masuda, et al.. (2012). An analysis of a second-line S-1 monotherapy for gemcitabine-refractory biliary tract cancer.. PubMed. 59(115). 691–5. 9 indexed citations
9.
Motoi, Fuyuhiko, Hiromune Shimamura, Masaya Oikawa, et al.. (2012). Sustained Elevation of Serum Tumor Markers after Resection is an Important Prognostic Factor for Pancreatic Cancer. The Japanese Journal of Gastroenterological Surgery. 45(7). 697–707. 1 indexed citations
10.
Rikiyama, Toshiki, Shinichi Egawa, Yu Katayose, et al.. (2011). Minimal Multiple Liver Metastases after Chemotherapy from Colorectal Cancer could be revealed with Intra Operative Ultrasonography using SONAZOIDTM. The Japanese Journal of Gastroenterological Surgery. 44(4). 490–496.
11.
Komatsu, Hirotake, Naoaki Sakata, Fuyuhiko Motoi, et al.. (2011). A case of intrahepatic cholangiocellular carcinoma occurring three years after resection for advanced pancreatic cancer. Suizo. 26(5). 589–597.
12.
Maeda, Shimpei, Fuyuhiko Motoi, Tohru Onogawa, et al.. (2011). Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study. International Journal of Clinical Oncology. 16(5). 539–545. 25 indexed citations
13.
Egawa, Shinichi, Hiroshi Yoshida, Fuyuhiko Motoi, et al.. (2011). A Case Report of Pancreatectomy Preserving the Middle Portion of the Pancreas for Arteriovenous Malformation of Pancreatic Head and Tail. The Japanese Journal of Gastroenterological Surgery. 44(12). 1573–1580. 1 indexed citations
14.
Sato, Ryuichiro, Takashi Suzuki, Yu Katayose, et al.. (2009). Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic Factors. Cancer Research. 69(3). 914–922. 56 indexed citations
15.
Sakata, Naoaki, Shinichi Egawa, Fuyuhiko Motoi, et al.. (2008). Institutional indications for islet transplantation after total pancreatectomy. Journal of Hepato-Biliary-Pancreatic Surgery. 15(5). 488–492. 12 indexed citations
16.
Sato, Ryuichiro, Masaya Oikawa, Yu Katayose, et al.. (2007). Surgical Resection for Gastric GIST with Multiple Liver Metastases after Imatinib Therapy. The Japanese Journal of Gastroenterological Surgery. 40(4). 427–432. 2 indexed citations
17.
Onogawa, Tohru, Takashi Suzuki, Takanori Ishida, et al.. (2007). Human liver‐specific organic anion transporter‐2 is a potent prognostic factor for human breast carcinoma. Cancer Science. 98(10). 1570–1576. 78 indexed citations
18.
Yoshida, Hiroshi, Yu Katayose, Michiaki Unno, et al.. (2003). A novel adenovirus expressing human 4–1BB ligand enhances antitumor immunity. Cancer Immunology Immunotherapy. 52(2). 97–106. 22 indexed citations
19.
Nakagawa, Kei, et al.. (2000). . Kanzo. 41(12). 823–828. 2 indexed citations
20.
Ebara, Shinji, Naoki Sakurai, Yu Katayose, et al.. (2000). Construction of a diabody (small recombinant bispecific antibody) using a refolding system. Protein Engineering Design and Selection. 13(8). 583–588. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yutaka Yonemura Breakdown of academic impact, for papers by Koji Okabayashi Breakdown of academic impact, for papers by Meier Hsu Breakdown of academic impact, for papers by Ryo Hosotani Breakdown of academic impact, for papers by Gakuji Ohshio Breakdown of academic impact, for papers by Uwe A. Wittel Breakdown of academic impact, for papers by Hironori Yamaguchi Breakdown of academic impact, for papers by Kenichi Harada Breakdown of academic impact, for papers by Tamas A. Gonda Breakdown of academic impact, for papers by Klaus Kaserer
Rankless by CCL
2026